Breaking News Instant updates and real-time market news.

FB

Facebook

$157.20

-2.14 (-1.34%)

09:40
04/09/18
04/09
09:40
04/09/18
09:40

Facebook forming commission to see how social media impacts elections

Elliot Schrage, Vice President of Communications and Public Policy, and David Ginsberg, Director of Research, said in a blog post: "Facebook is announcing a new initiative to help provide independent, credible research about the role of social media in elections, as well as democracy more generally. It will be funded by the John and Laura Arnold Foundation, Democracy Fund, the William and Flora Hewlett Foundation, the John S. and James L. Knight Foundation, the Charles Koch Foundation, the Omidyar Network, and the Alfred P. Sloan Foundation. At the heart of this initiative will be a group of scholars who will: Define the research agenda; Solicit proposals for independent research on a range of different topics; and Manage a peer review process to select scholars who will receive funding for their research, as well as access to privacy-protected datasets from Facebook which they can analyze. Facebook will not have any right to review or approve their research findings prior to publication. We're excited about this initiative for two important reasons. First, we think it's an important new model for partnerships between industry and academia. Second, the last two years have taught us that the same Facebook tools that help politicians connect with their constituents - and different communities debate the issues they care about - can also be misused to manipulate and deceive." Reference Link

  • 09

    Apr

  • 10

    Apr

  • 11

    Apr

  • 11

    Apr

  • 17

    Apr

  • 25

    Apr

FB Facebook
$157.20

-2.14 (-1.34%)

04/09/18
JEFF
04/09/18
NO CHANGE
Target $215
JEFF
Buy
Facebook headlines not hurting engagement on platform, says Jefferies
Jefferies analyst Brent Thill lowered his price target for Facebook to $215 from $230 reflect higher operating expenses. The analyst, however, keeps a Buy rating on the shares after analyzing Facebook's traffic over the course of March. Recent headlines around the company's data policies have not meaningfully impacted engagement on the platform, Thill tells investors in a research note titled "Data Shows Friends Don't Let Friends Leave Facebook." The analyst sees opportunity for long-term investors with Facebook shares currently trading at 18 times 2019 earnings estimates. Thill views the stock's current valuation as "compelling." He cautions, however, that near-term headline risk and Europe's data protection regulations could weigh on investor sentiment.
04/09/18
KEYB
04/09/18
NO CHANGE
Target $245
KEYB
Overweight
No meaningful impact on Facebook spending, says KeyBanc
KeyBanc analyst Andy Hargreaves says advertiser checks suggest no meaningful change in spending trends on Facebook and virtually no hesitancy from advertisers to continue spending. Engagement will be the key going forward in his view, and he sees limited signs of material impact to date. The analyst recommends buying Facebook, reiterating an Overweight rating and $245 price target on the shares.
04/05/18
WELS
04/05/18
NO CHANGE
Target $230
WELS
Outperform
Facebook expected to 'weather the storm,' says Wells Fargo
Wells Fargo analyst Ken Sena says his advertising and agency contacts continue to point to the fact that marketers with direct and purchased access to third party data will still be able to apply it to Facebook targeting. Moreover, combined with the fact that Facebook's first party data and advertiser's customer data will continue to be applicable to Facebook targeting, the analyst expects no material negative impact on advertiser spending. Sena reiterates an Outperform rating and $230 price target on the shares.
04/04/18
SPHN
04/04/18
NO CHANGE
Target $32
SPHN
Overweight
Acxiom overreaction to Facebook news a buying opportunity, says Stephens
Stephens analyst Brett Huff noted that Acxiom (ACXM) CEO Scott Howe published a blog post stating that he has seen "some signs" that Facebook (FB) is reconsidering its new policy on data imports in light of advertiser concerns. Huff, who thinks the blog post is a potential indication of the level of concern advertisers are having about Facebook's recent move, remains a buyer of Acxiom shares as he views the recent negative stock reaction to Facebook's news as overdone. He maintains his $32 price target and Overweight rating on Acxiom shares.

TODAY'S FREE FLY STORIES

REDU

Rise Education

$10.20

-0.22 (-2.11%)

16:38
11/15/18
11/15
16:38
11/15/18
16:38
Hot Stocks
Rise Education announces $30M share repurchase program »

Rise Education's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EHC

Encompass Health

$72.31

0.81 (1.13%)

16:37
11/15/18
11/15
16:37
11/15/18
16:37
Initiation
Encompass Health initiated  »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

HTHT

Huazhu Group

$28.59

0.64 (2.29%)

16:37
11/15/18
11/15
16:37
11/15/18
16:37
Earnings
Huazhu Group sees FY18 revenue growth at high end of 18%-22% range »

Consensus $1.42B. In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UHS

Universal Health

$127.90

0.61 (0.48%)

16:36
11/15/18
11/15
16:36
11/15/18
16:36
Initiation
Universal Health initiated  »

Universal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$28.59

0.64 (2.29%)

16:36
11/15/18
11/15
16:36
11/15/18
16:36
Earnings
Breaking Earnings news story on Huazhu Group »

Huazhu Group sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

HTHT

Huazhu Group

$28.59

0.64 (2.29%)

16:36
11/15/18
11/15
16:36
11/15/18
16:36
Earnings
Huazhu Group reports Q3 adjusted EPS 24c, one estimate 27c »

Reports Q3 revenue $403M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

REDU

Rise Education

$10.20

-0.22 (-2.11%)

16:35
11/15/18
11/15
16:35
11/15/18
16:35
Earnings
Rise Education reports Q3 EPS 9c, two estimates 12c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PEP

PepsiCo

$116.81

0.14 (0.12%)

16:35
11/15/18
11/15
16:35
11/15/18
16:35
Hot Stocks
PepsiCo maintains 92.75c per share dividend »

This dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

16:34
11/15/18
11/15
16:34
11/15/18
16:34
General news
Money Supply M2 Weekly Change data reported »

Week of 11/5 Money Supply…

16:34
11/15/18
11/15
16:34
11/15/18
16:34
General news
Fed Balance Sheet Level data reported »

Week of 11/14 Fed Balance…

AMH

American Homes 4 Rent

$19.87

-0.42 (-2.07%)

16:34
11/15/18
11/15
16:34
11/15/18
16:34
Downgrade
American Homes 4 Rent rating change  »

American Homes 4 Rent cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNVR

Univar

$23.10

0.07 (0.30%)

16:34
11/15/18
11/15
16:34
11/15/18
16:34
Hot Stocks
Univar, Buckman reach distribution pact for U.S., Canada »

Univar announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.28

0.67 (1.27%)

16:33
11/15/18
11/15
16:33
11/15/18
16:33
Hot Stocks
Bristol-Myers receives positive CHMP opinion recommending Opdivo plus Yervoy »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

KAMN

Kaman

$57.82

0.41 (0.71%)

16:32
11/15/18
11/15
16:32
11/15/18
16:32
Hot Stocks
Kaman awarded $52M addition to Option 14 of its USAF JPF order »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$99.62

-1.96 (-1.93%)

, CSCO

Cisco

$46.77

2.42 (5.46%)

16:32
11/15/18
11/15
16:32
11/15/18
16:32
OnTheFly
Fly Intel: Wall Street's top stories for Thursday »

Stocks opened in negative…

WMT

Walmart

$99.62

-1.96 (-1.93%)

CSCO

Cisco

$46.77

2.42 (5.46%)

FB

Facebook

$143.86

-0.39 (-0.27%)

QURE

uniQure

$31.00

8.21 (36.02%)

ORCL

Oracle

$50.64

1.8 (3.69%)

BRK.A

Berkshire Hathaway

$325,810.00

1410 (0.43%)

PCG

PG&E

$17.77

-7.89 (-30.75%)

DDS

Dillard's

$62.62

-11.01 (-14.95%)

NTAP

NetApp

$68.84

-9.21 (-11.80%)

BRK.B

Berkshire Hathaway

$217.49

1.465 (0.68%)

RYB

RYB Education

$7.82

-8.99 (-53.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 10

    Jan

INTC

Intel

$48.12

1.03 (2.19%)

16:31
11/15/18
11/15
16:31
11/15/18
16:31
Hot Stocks
Intel board approves $15B increase in authorized stock repurchase program »

Intel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TGT

Target

$80.76

-2.35 (-2.83%)

16:31
11/15/18
11/15
16:31
11/15/18
16:31
Initiation
Target initiated  »

Target initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Hot Stocks
Nvidia board authorizes additional $7B under share buyback program »

In November 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

LTRX

Lantronix

$3.51

0.03 (0.86%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Syndicate
Breaking Syndicate news story on Lantronix »

Lantronix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Hot Stocks
Nvidia raises quarterly dividend 7% to 16c per share »

Nvidia announced a 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Options
Preliminary option volume of 24.1M today »

Preliminary option volume…

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

, SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

16:29
11/15/18
11/15
16:29
11/15/18
16:29
Initiation
Golden Ocean, Scorpio Bulkers initiated  »

Golden Ocean, Scorpio…

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:28
11/15/18
11/15
16:28
11/15/18
16:28
Earnings
Nvidia sees Q4 revenue $2.7B, +/- 2%, consensus $3.4B »

GAAP and non-GAAP gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:27
11/15/18
11/15
16:27
11/15/18
16:27
Earnings
Nvidia reports Q3 adjusted EPS $1.84, consensus $1.71 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NCS

NCI Building

$12.25

-0.095 (-0.77%)

16:26
11/15/18
11/15
16:26
11/15/18
16:26
Hot Stocks
NCI Building shareholders vote in favor of merger with Ply Gem »

NCI Building's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.